SEC Form 4 · accession 0001140361-16-064063
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Avista Capital Partners II, L.P.
10% Owner
Avista Capital Partners II GP, LLC
10% Owner
ACP INC Research Co-Invest, LLC
10% Owner
Period of report
May 6, 2016
Accepted (ET)
May 9, 2016 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock, par value $0.01 per shareF1,F2,F3 | May 6, 2016 | S | 4,087,054 | $45.12 | D | 6,674,085 | I | Affiliated Funds |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Avista Capital Partners II GP, LLC ultimately exercises voting and dispositive power over the shares held by Avista Capital Partners II, L.P., Avista Capital Partners (Offshore) II, L.P., Avista Capital Partners (Offshore) II-A, L.P., ACP INC Research Co-Invest, LLC and INC Research Mezzanine Co-Invest, LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein, and the inclusion of shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities so disclaimed for purposes of Section 16 or for any other purpose.
- F2The shares were sold by the reporting person in a registered underwritten secondary offering pursuant to an underwriting agreement entered into on May 2, 2016.
- F3Represents public offering price of $45.12 per share.